Olga Radkevich-Brown, Ph.D. - Publications

Affiliations: 
2007 Cancer Biology Wayne State University, Detroit, MI, United States 
Area:
Oncology, Immunology

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Yang X, Zhang X, Mortenson ED, Radkevich-Brown O, Wang Y, Fu YX. Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 91-100. PMID 22990672 DOI: 10.1038/mt.2012.184  0.385
2010 Park S, Jiang Z, Mortenson ED, Deng L, Radkevich-Brown O, Yang X, Sattar H, Wang Y, Brown NK, Greene M, Liu Y, Tang J, Wang S, Fu YX. The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Cancer Cell. 18: 160-70. PMID 20708157 DOI: 10.1016/J.Ccr.2010.06.014  0.36
2010 Jacob JB, Quaglino E, Radkevich-Brown O, Jones RF, Piechocki MP, Reyes JD, Weise A, Amici A, Wei WZ. Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. Cancer Research. 70: 119-28. PMID 20048073 DOI: 10.1158/0008-5472.Can-09-2554  0.794
2010 Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ. Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression. Cancer Immunology, Immunotherapy : Cii. 59: 409-17. PMID 19730859 DOI: 10.1007/S00262-009-0760-1  0.675
2010 Jacob JB, Quaglino E, Radkevich-Brown O, Jones RF, Piechocki MP, Reyes JD, Weise A, Amici A, Wei WZ. Correction: Combining human and rat sequences in Her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity (Cancer Research (2010) 70, (119-128)) Cancer Research. 70: 2569. DOI: 10.1158/0008-5472.Can-10-0309  0.594
2009 Radkevich-Brown O, Jacob J, Kershaw M, Wei WZ. Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice. Cancer Research. 69: 212-8. PMID 19118005 DOI: 10.1158/0008-5472.Can-08-3092  0.693
2009 Whittington PJ, Radkevich-Brown O, Jacob JB, Jones RF, Weise AM, Wei WZ. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity. Cancer Immunology, Immunotherapy : Cii. 58: 759-67. PMID 18836716 DOI: 10.1007/S00262-008-0599-X  0.548
2008 Wei WZ, Jacob J, Radkevich-Brown O, Whittington P, Kong YC. The "A, B and C" of Her-2 DNA vaccine development. Cancer Immunology, Immunotherapy : Cii. 57: 1711-7. PMID 18273615 DOI: 10.1007/S00262-008-0464-Y  0.539
Show low-probability matches.